Brief: Gland Pharma Says CEO Shyamakant Giri Resigns Effective April 30, 2026
03/03/2026 13:59
March 3 (Reuters) - Gland Pharma Ltd GLAD.NS: CEO SHYAMAKANT GIRI RESIGNS EFFECTIVE APRIL 30, 2026 Source text: ID:nNSE4Syfgf Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant